KEY
PERSON
PERSON
The Device for local transdermal drug delivery and gene therapy developed by her became one of the best inventions according to IFIA (International Federation of Inventors’Associations), the Korean Intellectual Property Office (KIPO) and the Korea Women Inventors Association (KWIA) in 2024.
Under her leadership, transdermal technology ranked among the TOP-10 promising technologies globally by Sephora/LVMH.
Under her leadership, transdermal technology ranked among the TOP-10 promising technologies globally by Sephora/LVMH.
CEO, CO-founder YamaYami
Oksana Temirbekova
FACTS
The best innovative female manager among the BRICs
In 2021, she was named the best innovative female manager among BRIC countries by Deloitte.
MISSION
OUR
MISSION
Our mission is to improve the quality of human life through increasing the effectiveness of drugs.
Every day we work on the efficiency of drug delivery and increasing their effectiveness.
Markets for the technology application.
01
03
04
02
PEDIATRIC HEALTH TRACK
LOCAL GENE THERAPY
TRANSDERMAL VACCINATION
PROJECT
OUR
PRODUCT
BOTULINUM TOXIN DELIVERY
CONTACT
CONTACT
